2020
DOI: 10.1016/j.jpha.2020.08.006
|View full text |Cite
|
Sign up to set email alerts
|

Recent advances in construction of small molecule-based fluorophore-drug conjugates

Abstract: As a powerful tool to advance drug discovery, molecular imaging may provide new insights into the process of drug effect and therapy at cellular and molecular levels. When compared with other detection methods, fluorescence-based strategies are highly attractive and can be used to illuminate pathways of drugs’ transport, with multi-color capacity, high specificity and good sensitivity. The conjugates of fluorescent molecules and therapeutic agents create exciting avenues for real-time monitoring of drug delive… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
21
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 31 publications
(22 citation statements)
references
References 91 publications
0
21
0
1
Order By: Relevance
“…A biotinylated Tranilast analogue was prepared in a three‐step protocol, providing compound 3 yc in a 63 % overall yield. Small‐molecule‐based fluorophore–drug conjugates represent a valuable class of tool compounds for real‐time monitoring of drug delivery and distribution [7a] . The synthesis of molecular imaging tool compounds was exemplified with the Fluorescein‐tagged compound 3 yd .…”
Section: Resultsmentioning
confidence: 99%
“…A biotinylated Tranilast analogue was prepared in a three‐step protocol, providing compound 3 yc in a 63 % overall yield. Small‐molecule‐based fluorophore–drug conjugates represent a valuable class of tool compounds for real‐time monitoring of drug delivery and distribution [7a] . The synthesis of molecular imaging tool compounds was exemplified with the Fluorescein‐tagged compound 3 yd .…”
Section: Resultsmentioning
confidence: 99%
“…Deciphering the mechanism of action (MoA) of a bioactive molecule identified from a phenotypic screening approach is a key step to support its further pharmaceutical development into a drug. Cell imaging using a fluorescent version of a bioactive molecule is an enabling technology toward this end. , However, the nature and size of the labeling fluorophore attached to a small molecule often interfere with its ability to bind to the biological target of interest, thus limiting the validity of inherent cell imaging. Ideally, the fluorophore used should be as small as possible to most realistically reflect the original unlabeled molecule’s behavior . This is particularly true in the case of a lead compound identified from a phenotypic approach when its related biological target is unknown, and thus the assumption that the fluorophore should not interfere with this target cannot be virtually estimated.…”
mentioning
confidence: 99%
“…1−3 Cell imaging using a fluorescent version of a bioactive molecule is an enabling technology toward this end. 4,5 However, the nature and size of the labeling fluorophore attached to a small molecule often interfere with its ability to bind to the biological target of interest, thus limiting the validity of inherent cell imaging. 6−8 Ideally, the fluorophore used should be as small as possible to most realistically reflect the original unlabeled molecule's behavior.…”
mentioning
confidence: 99%
“…Binding quenching methods are static quenching and dynamic quenching . As a hypothetical dynamic quenching process, the quenching rate constants were determined using the Stern–Volmer equation where F and F 0 are the fluorescence intensity in the presence and absence of sulfamerazine, respectively, K q is the quenching rate constant, K sv is the Stern–Volmer constant, τ 0 is the fluorescence lifetime of sheep serum albumin in the absence of sulfamerazine (10 –8 s), and [Q] is the concentration of sulfamerazine.…”
Section: Resultsmentioning
confidence: 99%
“…Binding quenching methods are static quenching and dynamic quenching. 23 As a hypothetical dynamic quenching process, the quenching rate constants were determined using the Stern−Volmer equation ) where F and F 0 are the fluorescence intensity in the presence and absence of sulfamerazine, respectively, K q is the quenching rate constant, K sv is the Stern−Volmer constant, τ 0 is the Using eq 5, the quenching constant K q was 1.83 × 10 12 L mol −1 s −1 and K sv was 1.83 × 10 4 L mol −1 s −1 . The obtained K q values are on a scale of 10 12 L mol −1 s −1 , which far exceeds the diffusion-controlled rate constant in aqueous solution, i.e., 2.0 × 10 10 L mol −1 s −1 , confirming that quenching does not involve a dynamic diffusion process but occurs statically in complex.…”
mentioning
confidence: 99%